Flow Cytometry Approach for the Identification of Liposomal Cytarabine Toxicity

Dolores Subirá, Isabel López San Román, Dunia de Miguel, Miguel Díaz-Morfa, Isabel Izquierdo, Nuria Golbano, Carolina Cerrato, M. Dolores Morales, Sonia Herrero, Jaime Arbeteta, Felix Fuertes, Blanca Pinedo


Neurological complications may develop either at diagnosis or during the course of many hematological malignancies after initiation of therapy. The etiology might be very different but, once infection is excluded, differential diagnosis is mainly focused on distinguishing between leptomeningeal progression and toxicity secondary to therapy. In each case, the subsequent clinical decision would be completely opposite. Contrast central nervous system magnetic resonance, biochemistry, serology and cultures of the cerebrospinal fluid, and electromyography are usually performed in these patients, but demonstration of toxicity remains a diagnosis of exclusion for reagents such as liposomal cytarabine. Based on the experience of 2 clinical cases, we reviewed a database of immunophenotypic studies of the cerebrospinal fluid, and then we summarize how to use flow cytometry to positively support liposomal cytarabine toxicity.

J Neurol Res. 2012;2(2):48-53
doi: https://doi.org/10.4021/jnr95w


Flow cytometry; Cerebrospinal fluid; Liposomal cytarabine toxicity

Full Text: HTML PDF

Browse  Journals  


Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics


World Journal of Oncology

Gastroenterology Research

Journal of Hematology


Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity


Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research


Journal of Neurology Research

International Journal of Clinical Pediatrics



Journal of Neurology Research, biannually, ISSN 1923-2845 (print), 1923-2853 (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.neurores.org   editorial contact: editor@neurores.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.

Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.